SCHEMBL7507986

SCHEMBL7507986

CC(C)CC(C[PH](=O)OCCc1ccc(Cc2ccccc2)cc1)C(=O)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.41
▸ CTSB P07858 1/20 0.40
▸ CTSK P43235 2/20 0.38
▸ CA5A P35218 1/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CTSS P25774 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7500022 0.92 NPC1 (0.43) HSD17B10CTSBCTSKCA5A
SCHEMBL7546570 0.89 MMP1 (0.39) MMP1
SCHEMBL7550435 0.86 MEN1 (0.45) HSD17B10CTSKALDH1A1
SCHEMBL7602074 0.85 PPARA (0.45) —
SCHEMBL7548309 0.83 MMP1 (0.33) MMP1
SCHEMBL9503074 0.81 HSD17B10 (0.47) HSD17B10CTSBCTSKALDH1A1CTSS
SCHEMBL9506271 0.81 HSD17B10 (0.49) HSD17B10CTSBCTSKALDH1A1CTSS
SCHEMBL7505198 0.81 HSD17B10 (0.49) HSD17B10CTSBCTSKALDH1A1CTSS
SCHEMBL7506441 0.73 PPARA (0.47) ALDH1A1
SCHEMBL8048833 0.71 HSD17B10 (0.52) HSD17B10CTSBCTSKALDH1A1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923585-B1 PHOSPHINATE BASED INHIBITORS OF MATRIX METALLOPROTEASES PFIZER (US) 2002-05-08 — — EP disclosed
US-6147061-A ANTIARTHRITIC AGENTS; ANTICANCER AGENTS; ORAL DISEASES PFIZER INC. (US) 2000-11-14 — — US disclosed
EP-0923585-A1 PHOSPHINATE BASED INHIBITORS OF MATRIX METALLOPROTEASES PFIZER INC. (US) 1999-06-23 — — EP disclosed
WO-1998003516-A1 PHOSPHINATE BASED INHIBITORS OF MATRIX METALLOPROTEASES PFIZER INC. (US) 1998-01-29 — — WO disclosed
Send feedback